3/23/2024

がん検診（笑）


2024年3月23日土曜日

キャサリン妃ががんを公表

https://jyado.blogspot.com/2024/03/blog-post_64.html
命が助かるという保証はどこにもない…現役医師が｢がん検診は受けるだけムダ｣と考えるワケ時間とお金と体力を浪費するだけ
PRESIDENT Online
久坂部 羊小説家、医師
2022/12/19 13:00
https://president.jp/articles/-/64338



2017年6月28日水曜日

自分自身で治せないガンは医師にも霊媒師にも教祖様にも超能力者など他人には治せません

がん検診伸び悩み　16年、50％超は男性肺がんのみ
日本経済新聞：2017/6/28 0:11

https://tokumei10.blogspot.com/2017/06/blog-post_368.html

まあケイトは立場上強制的にきもせらぴいですな。お気の毒さま。

Why Kate Middleton is getting preventative chemotherapy: What next for the Princess's cancer recovery and the side effects of the intense treatment she will be undergoing
By STEPHEN MATTHEWS
PUBLISHED: 04:41 EDT, 23 March 2024 | UPDATED: 06:10 EDT, 23 March 2024

https://www.dailymail.co.uk/news/article-13230363/Kate-chemotherapy-Princesss-cancer-recovery-treatment.html


抗原原罪人にキーモはヤバいかもね。 

、、、（爆ｗｗｗｗｗｗｗ
時刻:

9 件のコメント:

  1. 匿名2024年3月23日 21:32

    Britain faces worst sickness crisis since 1990s as millions quit workforce. Britain is on the cusp of the worst sickness crisis on record following a post-lockdown surge in worklessness that is driving a “rapid rise” in benefit claims.7 時間前

    Britain faces worst sickness crisis since 1990s as millions quit ...

    The Telegraph
    https://www.telegraph.co.uk › business › 2024/03/23

    返信削除
  2. 匿名2024年3月23日 22:08

    ガーンwww
    研心wwww

    返信削除
  3. 匿名2024年3月24日 4:00

    がん検診で顧客を発見しないと、ガン治療で大儲けできない

    返信削除
  4. 匿名2024年3月24日 5:00

    がん治療の大規模治験をやってほしい
    A群　標準治療　手術、抗がん剤、放射線治療
    B群　枇杷の種、フェンベンダゾール、イベルメクチン、重曹クエン酸、断砂糖、糖質控えめ
    C群　無治療で放置

    これでどれがいちばん効果があるかやってみればいいとおもう

    返信削除
    返信
    1. 匿名2024年3月25日 8:11

      B群には、高用量ビタミンC投与 も必要

      削除
  5. 匿名2024年3月24日 8:19

    The underdiagnosed threat of oropouche fever amidst dengue epidemics in Brazil
    Paulo Ricardo Martins-Filho
    Roberto Fernandes Soares-Neto
    Jerocílio Maciel de Oliveira-Júnior
    Cliomar Alves dos Santos Open AccessPublished:March 19, 2024DOI:https://doi.org/10.1016/j.lana.2024.100718

    Oropouche Fever (OF) is an emerging zoonotic arboviral disease caused by Oropouche Virus (OROV). Its transmission unfolds through two primary cycles: an urban cycle, predominantly facilitated by the Culicoides paraensis Goeldi mosquito bites in humans, and a more complex sylvatic cycle. This latter involves a diverse array of arthropod species, such as Aedes serratus, Culex quinquefasciatus, Coquillettidia venezuelensis, and other Culicoides, affecting numerous reservoir hosts including rodents, birds, and non-human primates.1

    The disease was first identified in Trinidad and Tobago during the 1950s, with OROV subsequently isolated in Brazil in 1960. Since then, OF has expanded its reach, primarily affecting the Amazon region and extending to countries across Central and South America, including Panama, Argentina, Bolivia, Ecuador, Peru, and Venezuela.2 The geographic spread of the disease is often driven by environmental changes, such as deforestation, disorganized urbanization, and climate alterations, facilitating vector proliferation. Furthermore, human mobility significantly contributes to the dissemination of the virus, underscoring the intricate interplay between environmental and social factors in OF’s expansion.1, 2, 3

    OF's incubation period ranges from 4 to 8 days, with clinical manifestations closely mimicking those of dengue and Chikungunya, including high fever, headache, arthralgia, myalgia, skin rashes, malaise, nausea, and vomiting. While most cases resolve within two weeks, severe complications, such as meningitis or encephalitis, may develop. The similarity of symptoms with other arboviruses poses a significant challenge for diagnosis, necessitating laboratory confirmation.4 Currently, treatment is primarily supportive, focusing on symptomatic relief, which underscores the importance of prevention and control strategies aimed at reducing vector mosquito populations and educating the public about transmission routes.1, 2, 3

    The recent confirmation of OF’s first case in Rio de Janeiro on February 29, 2024, involving a 42-year-old man returning from Amazonas, signals the virus’s spread beyond traditional hotspots such as Amazonas, Acre, and Rondônia. Additionally, the record of 1674 OF cases in Amazonas in 2024, a threefold increase from the previous year, underscores the disease’s alarming escalation.5 The concurrent dengue epidemic, with over one million cases reported in Brazil during the first two months of 2024, combined with the symptomatic overlap between OF and other arboviruses and limited diagnostic capabilities, suggests a probable underdiagnosis of OF. This scenario presents a formidable challenge to the health system, necessitating heightened vigilance for accurate disease identification and control.

    This situation demands a coordinated and proactive response from authorities, healthcare teams, researchers, and the international community. It is imperative to develop effective testing protocols, particularly in regions previously unacquainted with the disease. A detailed investigation of travel history, especially to the Amazon region, is vital for identifying and mitigating outbreaks, highlighting the urgency of informed prevention and control measures against the disease.


    Contributors
    All authors contributed equally to the manuscript.

    Declaration of interests
    The authors declare that there is no conflict of interest.

    Acknowledgements
    P.R.M.F. is a productivity fellow at the National Council for Scientific and Technological Development (CNPq), Brazil.
    Funding: There was no funding source.

    返信削除
  6. 匿名2024年3月24日 8:25

    >抗原原罪人にキーモはヤバいかもね。


    本当にキモい施羅卑を行っていたとするならば、若いので脆に影響を受け血舞って早々と★になるんですかね。その場合には、西洋医学の軽屠性を明らかにするための盛るもっとになっちまうんですね。

    返信削除
  7. GABRIEL2024年3月24日 13:47

    これはケイト妃を通じて
    結果的に抗原原罪人への警告に(苦

    癌発覚は従来では有り得ない進行癌
    手術で寛解なら儲けものだけど
    所謂標準治療ではケモも放射も
    セットメニューで不可避だから
    ケモの毒と放射線で身体を蝕まれて
    速やかに葬送されてしまう結末にと(苦

    返信削除
  8. 匿名2024年3月24日 15:27

    >お気の毒さま
    お気の毒

    返信削除

登録: コメントの投稿 (Atom)